Browse > Home / Pharmacy Industry News / DrugScope Responds To ‘Legal Highs’ Ban

DrugScope Responds To ‘Legal Highs’ Ban

August 28, 2009

Responding to today’s proclamation that GBL, ‘Spice; and BZP elect be made illegal under the Misuse of Drugs Act, Martin Barnes, chief executive of the unsalable article complaint charity DrugScope said:

“DrugScope supports the Government’s decision to follow the advice of the ACMD and make GBL and BZP Class C substances. While we also support the government’session intention to construction Spice a controlled deaden through narcotics, there is a question impression over the pronunciamento that it will be made a Class B, not a Class C drug. The ACMD’sitting reviewal of Spice concluded that it is potentially as harmful as cannabis but the body politic previously rejected the council’s advice that cannabis should remain a Class C substance.

“A review of the Misuse of Drugs Act was promised by the Government in January 2006, but was subsequently dropped. Given the number of substances being made illegal under the Act with the likely prospect of more to come, and in light of recent decisions by the Government not to follow the ACMD’session advice on the classification of cannabis and ecstasy, it is even else important that the classification system is reviewed.

“In recent months some DrugScope members acting in drug treatment services have reported some increase in the number of people experiencing problems with GBL. The drug is unpredictable, is linked to fatalities and in that place is evidence of people becoming dependent on it hinder prolonged use. It is important that treatment services are geared to identifying and supporting tribe by GBL related problems.

“Spice, while chemically different from cannabis, closely mimics the psychoactive effect of cannabis. The ACMD’s resolution to recommend that the substances in Spice be banned was unusual in that it was based on make manifest and concern respecting possible rather than actual proven harms.

“While we nurture the classification of substances such in the same proportion that GBL and BZP, the law lone is a blunt implement. The forthcoming FRANK campaign devise better make information about these substances more widely available. But we accept concerns that in lumping all these substances together as ‘legal highs’, the eminently expressive differences in the effects and potential harms strength be hard as being young people to identify. It is significant that public information and training campaigns are comprehensive and ongoing.”

Source
DrugScope

Written by Samanta · Filed Under Pharmacy Industry News